title: [An unexpected and severe infusion reaction induced by trastuzumab].
authors.affiliation: Dra. en Farmacia. FEA. Servicio de Farmacia. Hospital Clínico Universitario Virgen de la Arrixaca. España.. msacramento.diaz@carm.es.
authors.forename: M
authors.initials: M
authors.lastname: Sacramento Díaz-Carrasco
authors.affiliation: Lda. en Farmacia. FIR. Farmacia Hospitalaria. Servicio de Farmacia. Hospital Clínico Universitario Virgen de la Arrixaca. España..
authors.forename: C
authors.initials: C
authors.lastname: Ramírez
authors.affiliation: Lda. en Medicina. MIR. Servicio Oncología Médica. Hospital Clínico Universitario Virgen de la Arrixaca. España..
authors.forename: S
authors.initials: S
authors.lastname: Montenegro
authors.affiliation: Dr. en Medicina. Jefe de Sección Oncología Médica. Hospital Clínico Universitario Virgen de la Arrixaca. España..
authors.forename: J L
authors.initials: JL
authors.lastname: Alonso-Romero
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous / Q000009:adverse effects; D008875:Middle Aged; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab